| Small Lymphocytic Lymphoma studied in …STUDIED_INderived200 of 479show all (up to 200) |
|---|
| → studied in | NCT00923507recruiting Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04269902Phase 3 · recruiting Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05006716Phase 1/Phase 2 · recruiting A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943872Phase 3 · recruiting A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06973187Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05023980Phase 3 · active not recruiting A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963074Phase 2 · active not recruiting A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709000Phase 2 · not yet recruiting A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05947851Phase 3 · recruiting A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010). · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136559Phase 3 · recruiting A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784167recruiting Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218341Phase 4 · recruiting A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221500Phase 2 · recruiting A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02629809Phase 2 · active not recruiting Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07168486Phase 1 · enrolling by invitation CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739459Phase 2 · not yet recruiting Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06291220Phase 1 · active not recruiting A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061951Phase 2 · recruiting Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02910583Phase 2 · completed Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04169737Phase 2 · recruiting Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03625037Phase 1/Phase 2 · active not recruiting First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04542824Phase 1/Phase 2 · active not recruiting Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623541Phase 1/Phase 2 · active not recruiting Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225439Phase 1 · recruiting Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03666000Phase 1 · recruiting Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06564038Phase 1/Phase 2 · recruiting A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03824483Phase 2 · active not recruiting Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516093Phase 3 · recruiting Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07734038Phase 2 · recruiting Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048813Phase 3 · active not recruiting Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03701282Phase 3 · active not recruiting Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737981Phase 3 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07520006Phase 1/Phase 2 · recruiting Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06970743Phase 3 · active not recruiting A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02160015Phase 1 · active not recruiting Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07428707early Phase 1 · recruiting Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04007029Phase 1 · active not recruiting Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02966756Phase 2 · active not recruiting A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07774390recruiting Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05254743Phase 3 · recruiting A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06762431Phase 1/Phase 2 · recruiting Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756897Phase 2 · active not recruiting Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849713Phase 2 · recruiting Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07342478Phase 3 · recruiting ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02846623Phase 2 · active not recruiting Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533579Phase 1/Phase 2 · recruiting Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024706Phase 2 · recruiting Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07526597Phase 2 · not yet recruiting Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804686Phase 3 · recruiting A Long-term Extension Study of PCI-32765 (Ibrutinib) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06708897Phase 1 · recruiting A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738887Phase 2 · not yet recruiting Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967610Phase 2 · recruiting Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337829Phase 2 · completed Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364423Phase 1/Phase 2 · recruiting Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05371808recruiting Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05828589Phase 1 · terminated A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774654Phase 1 · active not recruiting CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04419519Phase 2 · active not recruiting Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03331198Phase 1/Phase 2 · active not recruiting Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131022Phase 1 · recruiting A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339922Phase 2 · active not recruiting Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860880NA · recruiting Combating Cancer-Related Fatigue: A Personalized Supportive Care Program · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07557056Phase 2 · not yet recruiting Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544785Phase 2 · recruiting Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02332980Phase 2 · completed Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516617Phase 2 · recruiting Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02007044Phase 2 · active not recruiting Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277729Phase 1/Phase 2 · active not recruiting A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04545762Phase 1 · recruiting Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636175early Phase 1 · recruiting 64Cu-LLP2A for Imaging Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03162536Phase 1/Phase 2 · active not recruiting A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505254Phase 2 · active not recruiting Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04892277Phase 1 · recruiting CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03960840Phase 1/Phase 2 · active not recruiting Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04722172Phase 2 · active not recruiting A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195633Phase 2 · recruiting Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01351896Phase 2 · active not recruiting Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962636NA · terminated Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588478Phase 2 · recruiting A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941716Phase 2 · recruiting Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246906Phase 2 · terminated Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362035Phase 1/Phase 2 · completed ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582159Phase 2 · not yet recruiting Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05718869Phase 2 · active not recruiting Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029443Phase 1/Phase 2 · active not recruiting ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771572Phase 1 · recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035331Phase 1/Phase 2 · completed Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231412Phase 3 · completed Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01500733Phase 2 · active not recruiting PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03479268Phase 1 · active not recruiting Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666038Phase 3 · active not recruiting Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06839053Phase 2 · recruiting Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05020678Phase 1 · active not recruiting NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02514083Phase 2 · active not recruiting A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01589302Phase 2 · active not recruiting PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04560322Phase 2 · recruiting Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183854Phase 2 · recruiting Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04488354Phase 1 · completed Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518555Phase 2 · completed Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07030400recruiting Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05147467Phase 2 · recruiting Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05388006Phase 2 · recruiting Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830137Phase 1 · recruiting A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02952508Phase 2 · active not recruiting Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135133Phase 2 · completed A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03547115Phase 1 · terminated A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476378NA · not yet recruiting A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05624554Phase 3 · active not recruiting A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218510Phase 2 · recruiting Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03336333Phase 3 · active not recruiting A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05479994Phase 2 · active not recruiting Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624633Phase 2 · active not recruiting Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282018Phase 1/Phase 2 · completed Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05336812Phase 2 · recruiting Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466122Phase 2 · recruiting Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06191887Phase 1 · recruiting B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677919Phase 2 · active not recruiting Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965493Phase 3 · active not recruiting A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740529Phase 1/Phase 2 · completed A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333262Phase 2 · recruiting Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04843904Phase 1 · active not recruiting Safe Accelerated Venetoclax Escalation in CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05417165Phase 2 · recruiting Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07014917Phase 2 · recruiting Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07108998Phase 2 · recruiting Study of Epcoritamab as a Consolidation Therapy in CLL/SLL · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03961672Phase 2 · active not recruiting Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07313982recruiting LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04230304Phase 2 · terminated Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04155710Phase 1 · completed Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01496976Phase 2 · completed Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02296918Phase 1 · completed Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02005289Phase 2 · completed Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05317936Phase 1/Phase 2 · terminated Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052695Phase 1/Phase 2 · recruiting Mosunetuzumab for CLL MRD Clearance · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04191187Phase 2 · completed Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05602363Phase 1 · recruiting AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02863692recruiting Registry of the German CLL Study Group · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168930Phase 2 · recruiting Zanubrutinib and Venetoclax in CLL (ZANU-VEN) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568553Phase 1 · completed Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958705Phase 2 · recruiting Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173790enrolling by invitation Watch and Wait or Worry and Wait in Indolent Lymphoma · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05643742Phase 1/Phase 2 · recruiting A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375619recruiting Long-term Follow-up Study of Patients Receiving CAR-T Cells · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05105841Phase 2 · completed Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520098Phase 2 · recruiting A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02153580Phase 1 · active not recruiting Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979076Phase 1/Phase 2 · not yet recruiting A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06978088Phase 2 · recruiting LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704323Phase 1 · recruiting CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722668Phase 2 · completed UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153330Phase 1 · terminated Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03133221Phase 2 · completed 1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01995669Phase 1/Phase 2 · completed Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303392Phase 1 · completed Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06839872Phase 2 · withdrawn A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalabrutinib Treatment for Adult Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04694560withdrawn A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04578600Phase 1 · completed CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04494503Phase 1/Phase 2 · recruiting Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03492125Phase 1/Phase 2 · terminated A Study Of The Selective PKC-β Inhibitor MS- 553 · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03734016Phase 3 · completed A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04553692Phase 1 · terminated Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04867915recruiting Study on the Diagnosis and Management of CLL in Italy by GIMEMA · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03893682Phase 1 · terminated A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781855Phase 1 · withdrawn Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072458Phase 1 · active not recruiting A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788639recruiting A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03088878Phase 1/Phase 2 · completed A Study of Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03410901Phase 1 · completed TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04358458Phase 1/Phase 2 · terminated First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521178withdrawn Cardiotoxicities in Patients Receiving BTKi · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03788291Phase 2 · completed Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01724346Phase 3 · completed Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659044Phase 2 · terminated Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03078855Phase 3 · completed A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04450069Phase 1 · completed CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682808Phase 1 · unknown A Study of FCN-338 in Patients With Chronic CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06547944Phase 1 · active not recruiting Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03406156Phase 3 · completed A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852822terminated Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04806035Phase 1 · terminated Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia · condition mapped ALIAS · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05360238Phase 1/Phase 2 · terminated Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645744terminated Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05272813Phase 1/Phase 2 · terminated A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05720052Phase 1/Phase 2 · terminated A Study of MS-553 in Patients With Relapsed or Refractory B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422393Phase 1 · active not recruiting Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279405Phase 1 · completed A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364033NA · not yet recruiting Biological and Clinical Efficacy of Shingrix in Patients With CLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892044Phase 1 · completed Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995536Phase 1 · withdrawn CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL · condition mapped CURATED_BROADER · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801525Phase 2/Phase 3 · terminated Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V) · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06367374Phase 2 · not yet recruiting MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL · condition mapped ONTOLOGY_EXACT · 479 trials mapped (141 active) | — | — | Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |